Skip to main content
PLOS One logoLink to PLOS One
. 2025 Sep 26;20(9):e0332116. doi: 10.1371/journal.pone.0332116

Stochastic modeling of intra- and inter-hospital transmission in Middle East respiratory syndrome outbreak

Youngsuk Ko 1, Jacob Lee 2, Eunok Jung 3,*
Editor: Eunha Shim4
PMCID: PMC12469155  PMID: 41004554

Abstract

Middle East Respiratory Syndrome (MERS) is an endemic disease that presents a significant global health challenge characterized by a high risk of transmission within healthcare settings. Understanding both intra- and inter-hospital spread of MERS is crucial for effective disease control and prevention. This study utilized stochastic modeling simulations to capture inherent randomness and unpredictability in disease transmission. This approach provides a comprehensive understanding of potential future MERS outbreaks under various scenarios in Korea. Our simulation results revealed a broad distribution of case number, with a mean of 70 and a prediction interval of [0, 315]. Additionally, we assessed the risks associated with delayed outbreak detection and investigated the preventive impact of mask mandates within hospitals. Our findings emphasize the critical role of early detection and the implementation of preventive measures in curbing the spread of infectious diseases. Specifically, even under the worst-case scenario of late detection, if mask mandates achieve a reduction effect exceeding 55%, the peak number of isolated cases would remain below 50. The findings derived from this study offer valuable guidance for policy decisions and healthcare practices, ultimately contributing to the mitigation of future outbreaks. Our research underscores the critical role of mathematical modeling in comprehending and predicting disease dynamics, thereby enhancing ongoing efforts to prepare for and respond to MERS or other comparable infectious diseases.

Introduction

Middle East respiratory syndrome (MERS) results from infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) [1], a zoonotic pathogen capable of transmission between animals and humans. Clinically, MERS patients exhibit varying degrees of symptoms, including fever, cough, and shortness of breath [2]. Disease progression leads to complications such as pneumonia, acute respiratory distress syndrome, kidney failure, and multiorgan dysfunction. The average fatality rate stands at approximately 36%, with regional variations ranging from 14% to 44% [35] based on reported cases. MERS was initially identified in Saudi Arabia in 2012 [2] and continues to sporadically emerge in endemic regions, notably Saudi Arabia, which reports the highest case count [5]. As of 2024, Saudi Arabia has documented 2,204 cases, resulting in 862 deaths [5].

Subsequent to Saudi Arabia, South Korea reported the second highest incidence of MERS infections, predominantly linked to a single outbreak. In 2015, Korea faced a MERS outbreak originating from an individual who had recently visited the Middle East [6,7]. The disease primarily disseminated within hospital settings, resulting in 186 confirmed cases and 36 fatalities—a significant public health challenge for the country [8]. Notably, this outbreak exhibited a pronounced risk of transmission within hospitals, while general community spread remained limited [9,10]. These dynamics emphasize the critical need to comprehend both intra- and inter-hospital MERS transmission pathways for effective disease management and prevention.

Mathematical modeling plays a crucial role in investigating infectious diseases, offering a structure approach for deciphering and forecasting transmission dynamics [11]. Key advantages of such models lie in their ability to yield quantitative insights. By capturing intricate interactions among hosts, pathogens, and the environment, these models facilitate outbreak prediction, intervention assessment, and informed public health policy. Unlike decisions based on general observations, these models rely on precise numerical data. Policymakers benefit from these accurate data when evaluating potential interventions, such as vaccination campaigns, travel restrictions, and enforcing social distancing measures [1214]. Specifically for MERS, mathematical models have been pivotal in uncovering transmission patterns, predicting outbreaks, and identifying effective public health measures [15,16]. Assessments have highlighted the potential for sustained MERS transmission, emphasizing hospital-based spread [17,18]. Investigating superspreading events relative to the basic reproductive number has been pivotal [19,20]. Agent-based modeling techniques illuminate the impact of superspreading events on the MERS transmission dynamics of MERS, particularly during the Korean outbreak [21].

In this study, we utilize stochastic modeling simulations to capture the inherent randomness and unpredictability of disease spread, encompassing both intra- and inter-hospital transmission dynamics. Our model yields a comprehensive understanding of future MERS outbreaks across diverse scenarios, informing effective control strategies in South Korea. Our investigation focused on Gangnam District in Seoul, Korea, which comprises two tertiary referral hospitals (average bed count: 1,533), two general hospitals (average bed count: 225), and 32 smaller hospitals (average bed count: 73) [23]. The local community population stands at 650,000 [24]. Notably, our analysis excluded smaller clinics. Additionally, we assess the risk associated with delayed outbreak detection and investigate the preventive impact of mask mandates within healthcare facilities. These considerations are important given the current global health landscape, where timely detection and preventive measures are essential in managing infectious disease spread. Our research aims to contribute to preparedness and response efforts for MERS and related infectious diseases, offering valuable insights to guide policy decisions and healthcare practices, ultimately mitigating future outbreaks.

Materials and methods

Stochastic modeling of MERS outbreak

Our model includes individuals who are either hospitalized or directly interacting with hospital settings in the Gangnam District, Seoul. Specifically, the included populations are inpatients, hospital visitors, and medical staff across 36 hospitals (two tertiary, two general, and 32 smaller hospitals). The simulation is initiated with the importation of a primary case into the local community (population: 650,000), and transmission dynamics are limited to hospital-related settings. We excluded small clinics that do not accommodate inpatients, due to lack of transmission data and limited epidemiological relevance. Additionally, we did not include individuals from the general community who had no hospital exposure during the outbreak.

We analyzed the following key outcome variables and the role of uncertainty-from the stochastic simulations:

  • Total number of individuals who became infected during the simulated outbreak.

  • Number of hospitals with at least one infected individual (i.e., where any exposed, infectious, hospitalized, or isolated individual is present).

  • Time elapsed from symptom onset of the index case to the isolation of the last infected individual.

  • Maximum number of individuals in the isolated compartment at any single point in time.

  • Daily number of individuals in exposed, infectious, and isolated states throughout the simulation.

  • Sensitivity analysis metric to quantify the influence of input parameters on the total number of infections.

Drawing upon the Susceptible-Exposed-Infectious-Recovered (SEIR) mathematical model, we constructed a framework that accounted for both intra- and inter-hospital transmission of MERS. Within our model, hosts traverse six epidemiological stages: susceptible (S), exposed (E), infectious (I), hospitalized (H), isolated (Q), and recovered (R). In the hospital context, hosts are further categorized into medical staff (subscript M), inpatients (P), and visitors (V). Asymptomatic cases were not separately modeled but were implicitly represented within either the infectious or hospitalized states. Superspreaders were not explicitly identified in order to reflect generalized transmission patterns rather than outlier-driven dynamics. Importantly, we did not differentiate superspreaders in this study. Fig 1 depicts the flowchart of our epidemiological model, illustrating disease progression stages. Solid arrows denote disease transmission pathways. The terms ΛMi, ΛPi, and ΛVi represent the force of infection for nosocomial infections, influenced by IMi, IPi, IVi, and Hi. Here, the superscript i denotes hospital identifiers. Additionally, Λ represents the force of infection for local spread, with contributions from I, IMi, and IVi. We assume a Markovian process for disease transmission, where future states depend solely on the current state, independent of preceding events. Dashed arrows with numerical labels indicate delayed reactions (non-Markovian process) in disease progression. To simulate disease spread, we aggregate recorded time delays and incorporate them into the model [25]. Transmission rates and reductions in intra-hospital transmission due to non-pharmaceutical interventions (NPIs) are estimated based on the Pyeongtaek St. Mary’s Hospital outbreak, the site of the initial hospital cluster infection [26]. We employed stochastic simulation based on a modified Gillespie algorithm, incorporating both Markovian (non-delayed) and non-Markovian (delayed) processes. Each simulation was initiated with the introduction of a single index case into the local community. For each scenario, we performed 10,000 independent simulation runs to capture the stochastic variability in transmission dynamics. Detailed description is in S1 Text [22].

Fig 1. Flow diagram of Middle East Respiratory Syndrome transmission model considering intra- and inter-hospital transmission.

Fig 1

Model simulation scenarios

We designed a series of simulation scenarios to assess outbreak dynamics under varying conditions. In the baseline scenario we assume 0% mask effectiveness—reflecting the low awareness and minimal mask use in Korean hospitals during the 2015 outbreak—while the observed reduction in intra-hospital transmission is modeled solely through post-recognition interventions. The scenarios are described below in sequential order:

  1. Baseline scenario: The index case is introduced into the community, and the outbreak is recognized 5 days after hospital admission. Hospital visits are prohibited at recognition, and intra-hospital transmission is reduced by 41.02% (S1 Text) [8]. Upon symptom onset, a host is randomly admitted to a hospital.

  2. Outbreak detection delay: We varied the detection delay from 1 to 28 days to evaluate the risk of late outbreak recognition.

  3. Mask intervention: We simulated the impact of intra-hospital mask mandates, assuming reduction effects in transmission ranging from 0% (baseline) to 80%.

Fig 2 shows the simulation flow, encompassing outbreak recognition and intervention application. Once the outbreak is identified, we implement NPIs: hospital visits are prohibited (i.e., SVi transitions to susceptible (S)), and the intra-hospital transmission rates decrease by 41.02%. The estimation of this reduction is detailed in S1 Text. Additionally, beyond the baseline scenario, we explore additional scenarios considering the following factors:

Fig 2. Flow of the simulation from the import of the primary case to the outbreak recognition and reactive interventions.

Fig 2

  • Delay in outbreak detection: The risk associated with outbreak recognition delay is investigated, considering a range from 1 to 28 days. Notably, for the baseline scenario, this delay is specifically quantified as five days.

  • Mask mandates in hospital: In hospital settings, the preventive impact of mask-wearing intervention is assessed accounting for mask type and enforcement. We assumed that implementing mask mandates would lead to a decrease in intra-hospital transmission rates. The resulting transmission reduction effect ranges from 0% (baseline scenario) to a maximum of 80% [27].

Not that based on Offeddu et al.’s meta-analysis (risk ratios 0.13–0.59, corresponding to 41–87% reduction in infection), we set the maximum mask effectiveness at 80%.

Lastly, we performed a sensitivity analysis to identify the key factors influencing the outbreak. Using Latin Hypercube Sampling, we quantified the Partial Rank Correlation Coefficient (PRCC) values [29]. Our model incorporated several input parameters: outbreak detection timing (τrec), intra-hospital transmission rates (βH), intra-hospital infectious period for the primary case (τ~IQ), intra-hospital infectious period excluding the primary case (τIQ), local transmission rate (βL), local infectious period for the primary case (τ~IH), local infectious period excluding the primary case (τIH), incubation period (τEI), and the number of hospital visitors (SVi). We performed 200,000 simulation runs, introducing a uniform variation of ±30% based on default baseline values. Notably, βH encompassed all transmission rates within the hospital. Additionally, we accounted for delay-inputs by adjusting the variation ratio using values generated during the model simulation. The output of the model represented the cumulative number of infections, capturing the transition from susceptible to exposed stage.

Results

We examined multiple scenarios to evaluate the impact of outbreak detection timing and hospital-based preventive interventions on nosocomial transmission dynamics. Specifically, we compared a baseline scenario—representing moderate early detection and no mask mandates—with alternative scenarios involving delayed detection (1 to 28 days), mask mandates with varying effectiveness (0% to 80%), and their combined effects. Each scenario was simulated using a stochastic framework to assess variability in outbreak size, duration, and peak burden.

Baseline scenario simulation and sensitivity analysis

In Fig 3, panels A, B, and C depict the distributions of confirmed cases, exposed hospitals, and outbreak duration, respectively. We define an exposed hospital as one that has at least one infected host (E, I, H). Outbreak duration is defined as the time from symptom onset of the index case to the isolation of the last infected host. Among the simulation runs, approximately 8% conclude without secondary infections. The mean number (95% prediction interval; PI) for confirmed cases, exposed hospitals, and outbreak duration are 70 ([0,315]), 3 ([1,12]), and 119 ([33,253]), respectively. Panel D presents a box-chart graph combining panels A and B, with a red asterisk marking the MERS outbreak in Korea in 2015 (case number: 186, exposed hospitals: 8). In the cases limited to the Gangnam region, there were 83 newly infected individuals at a single hospital (Samsung Medical Center), not including those who were transferred after being infected elsewhere [6,7]. To quantify the relationship between the total number of confirmed cases and the number of exposed hospitals across simulation runs, we calculated Pearson’s correlation coefficient [28]. Notably, a strong correlation exists between confirmed cases and exposed hospitals (coefficient: 0.70, p-value approximately zero). Similarly, panel E presents a scatter plot depicting the relationship between the number of confirmed cases and outbreak duration. The color scale indicates clustering, with samples closer to yellow representing stronger clustering. A correlation analysis yields a coefficient of 0.77, smaller than the previously estimated coefficient. Additionally, the associated p-value is close to 0.

Fig 3. Baseline simulation results of outbreak outcomes: Distribution of the number of confirmed cases, exposed hospitals, and outbreak duration (A, B, and C), Distribution of confirmed cases using a box-chart graph according to the range of exposed hospitals (D), Weighted scatter plot of the number of confirmed cases according to the outbreak duration (E).

Fig 3

From panels A to C, red dashed vertical lines indicate the actual outbreak outcome during the 2015 MERS outbreak in Korea, which is also marked using red triangle in a panel D.

Fig 4 shows the time series graphs of infected hosts. Panels A, B, and C correspond to the number of hosts in the exposed, infectious, and isolated states, respectively. The black curve represents the mean value, whereas the red area indicates the 95% PI. Approximately 60 days after the initial onset, the exposed and infectious stages peak mean values of 6 and 4, with 95% PI of [0,29] and [0,22], respectively. Notably, the number of isolated patients could exceed 100 considering the 95% PI.

Fig 4. Number of infected hosts in different stages: Disease-exposed (A), Infectious (B), Isolated (C).

Fig 4

Fig 5 illustrates the time-dependent PRCC values for each input. βH consistently exhibits the highest PRCC, ranging from 0.16 to 0.31 throughout the observation period. Following closely are τ~IQ (PRCC: [0.07, 0.12]) and τIQ (PRCC: [0.01, 0.21]). During the initial 15 days after onset, τ~IQ exhibits higher PRCC; however, τIQ surpasses it subsequently. The parameter βL has the second-highest PRCC values within the range [0.04, 0.08]. Notably, 87 days after onset, the PRCC of βL exceeds that of τ~IQ. Interestingly, τEI is the sole input among all factors where the sign of PRCC changes from positive to negative. Initially positive (maximum 0.03), PRCC transitions to negative (minimum -0.02) 13 days after the outbreak began. Additionally, τIH and SVi exhibited PRCC of 0.01 to 0.02 and –0.01 to 0.02, respectively, indicating a negligible effect on outbreak outcomes.

Fig 5. Results from the parameter sensitivity analysis, quantified using the Partial Rank Correlation Coefficient (PRCC).

Fig 5

Notably, the X-axis (time, days after onset) is log-scaled.

Risk of late detection and preventive impact of mask-wearing in hospital

To assess the effects of delayed outbreak recognition and hospital-based preventive interventions, we simulated additional scenarios varying the detection delay and the effectiveness of mask mandates. Specifically, we analyzed the peak number of isolated patients —a critical risk indicator—by simultaneously adjusting the outbreak detection delay and the effectiveness of mask mandates within hospitals. Fig 6 illustrates the results using filled contour plots, depicting the mean value (panel A) and the maximum value within the 95% PI (panel B). When mask mandates have no effect (represented by a value of 0 on the X-axis), the peak number of isolated patients can exceed 350 within the 95% PI if outbreak detection is delayed by up to 28 days. However, with the fastest detection (one day), the peak is expected to average approximately 25 and reach up to 125 within the 95% PI. When mask mandates have an effect exceeding 40%, the peak number of isolated patients—considering outbreak detection at its latest (28 days)—is smaller than the peak without mask mandates when comparing maximum values within the 95% PI. Furthermore, if the effect of mask mandates exceeds 70%, the maximum number of peak isolated patients within the 95% PI under late outbreak detection, is smaller than the mean when detection is fastest without mask mandates. The contour line representing the mean peak number of isolated patients at 50 is of particular significance. Without the effect of mask mandates, this threshold is achieved with a 12-day detection delay. When extrapolated to the far right, the contour line corresponds to a scenario involving a 28-day detection delay and a 30% impact from mask mandates.

Fig 6. Filled contour plots depict the peak number of isolated patients as a function of changes in the transmission reduction effect due to mask mandates and outbreak detection delay: Mean value (A), and Maximum value within the 95% PI (B).

Fig 6

Summary of scenario comparisons. Compared to the baseline scenario, delayed outbreak detection led to substantial increases in outbreak size and isolation burden. However, when moderate to high mask effectiveness (≥60%) was assumed, these effects were largely mitigated. The combined implementation of early detection and mask mandates was the most effective in reducing peak isolation burden. Overall, these results emphasize the critical role of timely outbreak recognition and intra-hospital interventions in minimizing outbreak impact.

Discussion

The baseline scenario simulation results revealed a broad distribution of case numbers, ranging from 0 to 315 within the 95% PI. Additionally, the simulation indicated a high probability of small-scale outbreaks (Fig 3A). This phenomenon arises because an outbreak initiated by a single case is significantly influenced by the individual events, potentially leading to early containment or limited transmission to the second or third generation of infection. Notably, the number of confirmed cases observed during the 2015 Korean fell slightly below the upper bound of the PI for the baseline scenario (upper 10%). When considering only the cases limited to the Gangnam District, the number falls within the upper 29% of the PI. Furthermore, when we further analyzed the simulation results by considering the number of hospitals exposed to the disease, the distribution of confirmed cases could vary (Fig 3D). In the 2015 simulation results, which align with the observed number of exposed hospitals (nine hospitals), the case represents the upper 44% of the distribution. Therefore, we can conclude that the 2015 scenario is not an unrealistic situation. Additionally, Fig 4 illustrates the estimated number of infected hosts at a specific time. This information serve as a reference for establishing tracking targets during contact tracing, particularly for epidemiological investigators, at the outset of an outbreak. For instance, 20 days after the primary case onset, the mean number of exposed and infectious hosts is 3 and 2 (with 95% PI [0,10] and [0,7]), respectively. However, there was a difference in the trend between our simulation results and the actual 2015 case, particularly in the outbreak duration. The simulation results showed an average outbreak duration of 119 days, whereas the actual outbreak in 2015 lasted for 54 days [8]. This difference arises from the characteristics of the model used in this study. The actual phenomenon was driven by a small number of superspreaders, but this study averaged the effects of all spreaders in the simulation.

The sensitivity analysis conducted on the baseline scenario yielded quantitative insights (Fig 5). Notably, the infectious period of the initial primary case was found to be more significant than that of the remaining infected individuals during the early phase of the outbreak, as revealed by the time-varying PRCC. In our investigation, we noted that the local community’s transmission rate significantly influenced the outbreak scale. This observation raises the question of whether NPIs are also warranted at the local community level. However, considering the socio-economic burden associated with implementing NPIs locally —a different scale from the hospital-level control measures—the results of our sensitivity analysis paradoxically underscores the importance of early detection of the index case (primary case) rather than immediate NPI application within the local community. Notably, during the COVID-19 pandemic, several countries, including Korea, faced a substantial increase in NPIs burden when the outbreak reached a nationwide scale [30,31].

Our simulation results reveal that rapid detection within hospitals can significantly mitigate outbreak scale, while delayed detection exacerbates the situation (Fig 6B). The peak size of isolated patients emerges as a critical factor affecting medical resources; exceeding local community capacity can lead to rapid deterioration [32]. In Gangnam district (2024), where 77 isolation beds are available [23], a detection delay of more than 18 days —without preventive mask mandates —could result in medical collapse. Our findings underscore the need for a constant level of isolation ward capacity and provide a realistic risk assessment (.g., a four-day detection delay after index admission corresponds to an upper-bound estimate of approximately 125 cases within the 95% PI).

One strength of this study is its flexible framework for evaluating multiple policy scenarios using stochastic modeling that reflects real-world delays and heterogeneity. Our use of epidemiologically-derived parameters and detailed simulation design enables realistic assessment of hospital-level transmission dynamics and control strategies. The limitations of this study are as follows: (1) The transmission rate within the hospital can be heterogeneous depending on the hospital environment; however, in this study, the parameters estimated from the Pyeongtaek St. Mary’s Hospital case were applied uniformly across all hospitals. (2) Unreported cases or superspreaders could not be distinguished. This resulted in a longer outbreak duration compared to the real outbreak case. (3) The phenomenon of doctor shopping, where the same patient visits multiple hospitals, was not considered [36]. (4) Patients transfer between hospitals and maximum isolation spaces capacity were also omitted. Future studies should address these limitations. (5) We excluded small clinics because they lack inpatient data and modeling thousands of tiny facilities exceeds our stochastic framework; we will address this in future agent-based work.

Conclusion

Our model focuses on both of inter- and intra-hospital transmission dynamics. Reflecting the minimal mask use and active visitation culture during the 2015 Korean MERS outbreak, we quantify how hospital-based mask madates can both curb nosocomial spreads and avert broader community outbreaks. Our findings highlight the critical role of early outbreak recognition and targeted hospital-level interventions in controlling nosocomial MERS transmission. Even under delayed detection, effective mask mandates can significantly reduce peak burden, underscoring their importance as a first-line defense in healthcare settings.

Recommendations

Based on our findings, we recommend prioritizing early outbreak recognition through streamlined diagnostic workflows in hospitals. Our simulation results indicate that even modest delays in detection can substantially increase outbreak size and isolation burden. In particular, detection delays beyond two weeks may exceed local isolation capacity unless mitigated by additional interventions.

We also recommend maintaining mask mandates within hospital settings during periods of emerging respiratory threats. Our results show that mask effectiveness of 60% or higher can partially compensate for delayed detection and significantly reduce peak isolation burden. Finally, maintaining a baseline level of surge capacity for isolation beds in densely populated urban areas may help buffer against sudden outbreak escalation.

Supporting information

S1 Text. Supplementary appendix.

This contains detailed explanation of methods for the research.

(PDF)

pone.0332116.s001.pdf (1.8MB, pdf)

Data Availability

The dataset and code used in this study are publicly available in the figshare repository at DOI: 10.6084/m9.figshare.26317555.v3 (https://doi.org/10.6084/m9.figshare.26317555.v3). There are no restrictions on data access.

Funding Statement

This research was supported by the Government-wide R&D Fund Project for Infectious Disease Research (GFID), Republic of Korea (grant No. HG23C1629). This paper is supported by the Korea National Research Foundation (NRF) grant funded by the Korean government (MEST) (NRF-2021R1A2C100448711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. The Lancet. 2015;386(9997):995–1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–20. doi: 10.1056/NEJMoa1211721 [DOI] [PubMed] [Google Scholar]
  • 3.Majumder MS, Rivers C, Lofgren E, Fisman D. Estimation of MERS-coronavirus reproductive number and case fatality rate for the Spring 2014 Saudi Arabia outbreak: insights from publicly available data. PLoS Curr. 2014;6:ecurrents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c. doi: 10.1371/currents.outbreaks.98d2f8f3382d84f390736cd5f5fe133c [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chen X, Chughtai AA, Dyda A, MacIntyre CR. Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea. Emerg Microbes Infect. 2017;6(6):e51. doi: 10.1038/emi.2017.40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World Health Organization. MERS situation update, May 2024 . [cited 2024 May]. https://www.emro.who.int/health-topics/mers-cov/mers-outbreaks.html
  • 6.Ki M. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health. 2015;37:e2015033. doi: 10.4178/epih/e2015033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cho SY, Kang J-M, Ha YE, Park GE, Lee JY, Ko J-H, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet. 2016;388(10048):994–1001. doi: 10.1016/S0140-6736(16)30623-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ministry of Health and Welfare R of K. 2015 MERS white paper. https://www.mohw.go.kr/board.es?mid=a10411010100&bid=0019&tag=act=view&list_no=337407
  • 9.Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017;95(2):207–13. doi: 10.1016/j.jhin.2016.10.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ha K-M. A lesson learned from the MERS outbreak in South Korea in 2015 . J Hosp Infect. 2016;92(3):232–4. doi: 10.1016/j.jhin.2015.10.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Siettos CI, Russo L. Mathematical modeling of infectious disease dynamics. Virulence. 2013;4(4):295–306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021;21(6):793–802. doi: 10.1016/S1473-3099(21)00143-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Camitz M, Liljeros F. The effect of travel restrictions on the spread of a moderately contagious disease. BMC Med. 2006;4:32. doi: 10.1186/1741-7015-4-32 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kim S, Ko Y, Kim Y-J, Jung E. The impact of social distancing and public behavior changes on COVID-19 transmission dynamics in the Republic of Korea. PLoS One. 2020;15(9):e0238684. doi: 10.1371/journal.pone.0238684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nah K, Otsuki S, Chowell G, Nishiura H. Predicting the international spread of Middle East respiratory syndrome (MERS). BMC Infect Dis. 2016;16:356. doi: 10.1186/s12879-016-1675-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sardar T, Ghosh I, Rodó X, Chattopadhyay J. A realistic two-strain model for MERS-CoV infection uncovers the high risk for epidemic propagation. PLoS Negl Trop Dis. 2020;14(2):e0008065. doi: 10.1371/journal.pntd.0008065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Choi S, Jung E, Choi BY, Hur YJ, Ki M. High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea. Journal of Hospital Infection. 2018;99(2):162–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 2015;13:210. doi: 10.1186/s12916-015-0450-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lee J, Chowell G, Jung E. A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events. J Theor Biol. 2016;408:118–26. doi: 10.1016/j.jtbi.2016.08.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Alasmawi H, Aldarmaki N, Tridane A. Modeling of a super-spreading event of the MERS-corona virus during the Hajj season using simulation of the existing data. International Journal. 2017;1(1):25. [Google Scholar]
  • 21.Kim Y, Ryu H, Lee S. Agent-based modeling for super-spreading events: a case study of MERS-CoV transmission dynamics in the Republic of Korea. Int J Environ Res Public Health. 2018;15(11):2369. doi: 10.3390/ijerph15112369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Slayton RB, O’Hagan JJ, Barnes S, Rhea S, Hilscher R, Rubin M, et al. Modeling Infectious Diseases in Healthcare Network (MInD-Healthcare) framework for describing and reporting multidrug-resistant organism and healthcare-associated infections agent-based modeling methods. Clin Infect Dis. 2020;71(9):2527–32. doi: 10.1093/cid/ciaa234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Health Insurance Review & Assessment Service. Nationwide status of hospitals and pharmacies. [cited 2023 Oct 1]. https://opendata.hira.or.kr/op/opc/selectOpenData.do?sno=11925&publDataTpCd=&searchCnd=&searchWrd=
  • 24.Ministry of the Interior and Safety. Population by administrative district (city, county, district) and gender. Ministry of the Interior and Safety. [cited 2023 Oct 1]. https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B040A
  • 25.Virlogeux V, Park M, Wu JT, Cowling BJ. Association between severity of MERS-CoV infection and incubation period. Emerg Infect Dis. 2016;22(3):526–8. doi: 10.3201/eid2203.151437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kim KM, Ki M, Cho SI, Sung M, Hong JK, Cheong HK, Kim JH, Lee SE, Lee C, Lee KJ, Park YS. Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary’s Hospital. Epidemiology and Health. 2015;37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Offeddu V, Yung CF, Low MSF, Tam CC. Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(11):1934–42. doi: 10.1093/cid/cix681 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fisher RA. Statistical methods for research workers. Breakthroughs in statistics: Methodology and distribution. New York: Springer; 1970. p. 66–70.
  • 29.Marino S, Hogue IB, Ray CJ, Kirschner DE. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol. 2008;254(1):178–96. doi: 10.1016/j.jtbi.2008.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Atalan A. Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective. Annals of Medicine and Surgery. 2020;56:38–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Onyeaka H, Anumudu CK, Al-Sharify ZT, Egele-Godswill E, Mbaegbu P. COVID-19 pandemic: a review of the global lockdown and its far-reaching effects. Sci Prog. 2021;104(2):368504211019854. doi: 10.1177/00368504211019854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sprung CL, Zimmerman JL, Christian MD, Joynt GM, Hick JL, Taylor B, et al. Recommendations for intensive care unit and hospital preparations for an influenza epidemic or mass disaster: summary report of the European Society of Intensive Care Medicine’s Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Intensive Care Med. 2010;36(3):428–43. doi: 10.1007/s00134-010-1759-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ezhilan M, Suresh I, Nesakumar N. SARS-CoV, MERS-CoV and SARS-CoV-2: a diagnostic challenge. Measurement. 2021;168:108335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Mustafa HM, Abdulateef DS, Rahman HS. Misdiagnosis of COVID-19 infection before molecular confirmation in Sulaimaniyah City, Iraq. Eur J Med Res. 2022;27(1):84. doi: 10.1186/s40001-022-00704-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Korea Policy Briefing. No need to wear masks in hospitals from today... Downgrading of COVID-19 crisis level to ‘attention.’ [Internet]. [cited 2023 Oct 1]. https://www.korea.kr/news/policyFocusView.do?newsId=148928706bbsKey=pageIndex=1pkgId=49500742pkgSubId=pkgSubs=exceptNewsId=cardYn=cateId=cateIds=sectId=sectIds=nCateIds=nSectIds=dataValue=srchWord=repCode=repText=
  • 36.Shin N, Kwag T, Park S, Kim YH. Effects of operational decisions on the diffusion of epidemic disease: a system dynamics modeling of the MERS-CoV outbreak in South Korea. J Theor Biol. 2017;421:39–50. doi: 10.1016/j.jtbi.2017.03.020 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Eunha Shim

5 May 2025

PONE-D-25-03162Stochastic Modeling of Intra- and Inter-Hospital Transmission in Middle East Respiratory Syndrome OutbreakPLOS ONE

Dear Dr. Jung,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Eunha Shim

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

3. Please note that your Data Availability Statement is currently missing the repository name. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: - Introduction:

The background related to Gangnam District in Seoul, Korea, and the two surveyed hospitals should be mentioned here (population study)

- Methods:

o Add information on the sampling methodology

o Inclusion/exclusion criteria

o List and define variables to be analyzed

o The various scenarios and their sequence should be indicated, from baseline to other models

o The sensitivity analysis to be mentioned as well

- Results:

The results for each model should be described more systematically, and summarized. What has changed between the baseline model and the other model?

- Discussion:

Each result should be discussed more systematically and following the order of appearance in the results section

- Strengths and Limitations of this study should be indicated separately

- A section on Conclusion is to be added separately

- A separate section on Recommendations to be added as well

Reviewer #2: Reviewer report

Manuscript: PONE-D-25-03162

Title: Stochastic Modeling of Intra- and Inter-Hospital Transmission in Middle East

Respiratory Syndrome Outbreak

Summary:

The study used stochastic modeling simulation approaches to understand MERS transmission dynamics with inherent randomness and unpredictability, with hope that the outcomes will guide disease management policy decisions. The methods as described are too shallow and need to be more detail as this is very important in reporting modeling work to ensure reproducibility of the study. Some few sentences need to be rephrased as well. Some of the content is misplaced e.g. some stuff suitable for materials and methods is wrongly introduced in the results section e.g. under sensitivity analysis.

Major observation:

1. The materials and methods are too shallow and hard to comprehend. Introduce key steps in this section and describe them concisely. For example, the statistical methods used in assessing correlations between correlation exists between confirmed cases and exposed hospitals need to be described among others.

2. In materials and methods, you mention that your analysis ignored smaller clinics. Much as this could be a simplifying assumption, it may impact the study outcomes. Investigate (as a sensitivity analysis) how their inclusion would affect the study outcomes.

3. For improved content flow, some key informative details on model building and parameterization need to be (concisely) introduced in the main text instead of supplementary material. E.g., in line 83, on how was the value of 59% arrived? This and other similar mentions need description instantly. You can keep the detailed descriptions about the same parameters in the supplementary file.

4. How realistic is the assumption of 0% mask use impact in the baseline scenario? It is a known fact that irrespective of the prevailing circumstances, some people would be using masks anyway. This need to be revised.

5. What informed your choices for the ranges explored in the alternative scenarios explored? Justification should be added to the main text and practicality and feasibility should be key. You cite [28] on 80% the second scenario, (concisely and briefly) describe how they came up with that number in the main text.

6. The code used for the sensitivity analysis should be provided as part of the supplementary information files.

7. Rearrange your contact to ensure that content appears where it is most suited. Case in point is the description on sensitivity analysis (in lines 121-132) that you introduce in the results section yet it is methods.

Some of the minor observations:

8. Tense and grammar edits are needed e.g. in abstract where you write “Our findings emphasized…” shouldn’t it be “emphasize”?

9. Line 14: replace “singular” with “single”

10. Line 47: delete “of”

11. Under materials and methods, separate data description and model description in the first subheading.

12. Line 68: wrong phrasing in “To simulate our model…”. It is not the model that you are simulating rather it is the disease spread that you are simulating using the model

13. Line 97: use “distribution” instead of “distributions”?

14. Check and revise the flow of the sentence in line 98.

15. Line 146: what are those two factors? Mention them explicitly or improve sentence flow.

Reviewer #3: 1. The authors must provide the complete code to reproduce all model fitting procedures and simulation output presented in the manuscript.

2. There is already a substantial modeling study of the MERS. What is the unique contribution of this work, and how does the model offer meaningful insights or practical relevance in the current context?

3. The study assumed that the number of hospital visitors equals to the number of inpatients. Is there a reference to support this assumption? In addition, a sensitivity analysis exploring how variations in the ratio of hospital visitors to inpatients affect the model outcomes should be conducted and included.

4. In Figure 1, which presents a diagram of the model, the solid arrows represent the pathways of the infection transmission. However, it is unclear what the dotted arrows and red dotted arrows indicate. Additionally, both I_V^i and I flow into “red (2)”, but it is unclear what this “red (2)” signifies. Is it not a specific compartment? Why was it depicted in red?

5. The equations in the Supporting Information (S1 text) need to be organized, as some equations are repeated. Furthermore, based on the diagram in Figure 1, I_M^i, I_P^i, and H^i flow into Q^i. However, the equations state (dQ^i)/dt=I_M^i (t-τ_(I→Q) )+I_P^i (t-τ_(I→Q) )+I_V^i (t-τ_(I→Q) )-Q^i (t-τ_(Q→R)). The author could provide a more detailed explanation or clarification.

Reviewer #4: The article “Stochastic Modeling of Intra- and Inter-Hospital Transmission in Middle East Respiratory Syndrome Outbreak” models the spread of MERS within hospitals and the general population in the Gangnam District of Seoul, Korea. The authors use the model to predict outputs such as the size of the outbreak, number of exposed hospitals, and outbreak duration and assess the effect of mask mandates on the results. I thought the article was very well written, the methodology sound, and interpretation reasonable. My comments are generally minor. Please see the attached document for the comments.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Amos Ssematimba

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Korea_MERS_review.docx

pone.0332116.s002.docx (15.4KB, docx)
PLoS One. 2025 Sep 26;20(9):e0332116. doi: 10.1371/journal.pone.0332116.r002

Author response to Decision Letter 1


14 Jul 2025

Dear Reviewers,

Thank you for insightful comments. We have revised paper and attached the response as word file.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0332116.s003.docx (224.3KB, docx)

Decision Letter 1

Eunha Shim

27 Aug 2025

Stochastic Modeling of Intra- and Inter-Hospital Transmission in Middle East Respiratory Syndrome Outbreak

PONE-D-25-03162R1

Dear Dr. Jung,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Eunha Shim

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All comments have been addressed. The publication criteria have been met. I have no further comment.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

Reviewer #4: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Amos Ssematimba

Reviewer #3: No

Reviewer #4: No

**********

Acceptance letter

Eunha Shim

PONE-D-25-03162R1

PLOS ONE

Dear Dr. Jung,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Eunha Shim

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Supplementary appendix.

    This contains detailed explanation of methods for the research.

    (PDF)

    pone.0332116.s001.pdf (1.8MB, pdf)
    Attachment

    Submitted filename: Korea_MERS_review.docx

    pone.0332116.s002.docx (15.4KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0332116.s003.docx (224.3KB, docx)

    Data Availability Statement

    The dataset and code used in this study are publicly available in the figshare repository at DOI: 10.6084/m9.figshare.26317555.v3 (https://doi.org/10.6084/m9.figshare.26317555.v3). There are no restrictions on data access.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES